Anti-angiogenesis effect of generation 4 polyamidoamine/vascular endothelial growth factor antisense oligodeoxynucleotide on breast cancer in vitro

Journal of Zhejiang University: Science B

Volumn 10, Issue 3, 2009, Pages 159-167

  Gu, Shan Zhi ^a   Zhao, Xin Han ^a   Zhang, Ling Xiao ^a   Li, Li ^a   Wang, Zhi Yu ^a   Meng, Min ^a   An, Gai Li ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Breast cancer; Generation 4 polyamidoamine (G4PAMAM); Generation 4 polyamidoamine vascular endothelial growth factor antisense oligodeoxynucleotide (G4PAMAM VEGFASODN); Vascular endothelial cell; Vascular endothelial growth factor (VEGF); VEGF mRNA

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; POLYAMIDOAMINE; TETRAZOLIUM; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTISENSE THERAPY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRIMERS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, TRANSMISSION; NYLONS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 62549144439     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0820175     Document Type: Article

References (16)

1. Alton, E., 2007. Progress and prospects: Gene therapy clinical trials (part 1). Gene Ther., 14(20):1439-1447. [doi:10. 1038/sj.gt.3303001]
2. Bertolini, F., Mancuso, P., Shaked, Y., Kerbel, R.S., 2007. Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discov. Today, 12(19-20):806-812. [doi:10.1016/j.drudis.2007.08.011]
3. Devarakonda, B., Otto, D.P., Judefeind, A., Hill, R.A., de Villiers, M.M., 2007. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. Int. J. Pharm., 345(1-2):142-153. [doi:10.1016/j.ijpharm.2007.05.039]
4. Edelstein, M.L., Abedi, M.R., Wixon, J., 2007. Gene therapy clinical trials worldwide to 2007 - an update. J. Gene Med., 9(10):833-842. [doi:10.1002/jgm.1100]
5. Esfand, R., Tomalia, D.A., 2001. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today, 6(8): 427-436. [doi:10.1016/S1359-6446(01)01757-3]
6. Flotte, T.R., 2007. Gene therapy: The first two decades and the current state-of-the-art. J. Cell. Physiol., 213(2):301-305. [doi:10.1002/ jcp.21173]
7. Guo, C., Wang, H., Lin, Y., Cai, Q., 2004. Application of Starburst (TM) PAMAM dendrimers as DNA carriers in vitro. Prog. Biochem. Biophys., 31(9):804-811.
8. Hattori, Y., Ding, W., Maitani, Y., 2007. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. Journal of Controlled Release, 120(1-2):122-130. [doi:10.1016/j.jconrel.2007.04.012]
9. Hayes, D.F., Miller, K., Sledge, G., 2007. Angiogenesis as targeted breast cancer therapy. Breast, 16(2):17-19. [doi:10.1016/ j.breast.2007.07.003]
10. Miller, A.D., 2003. The problem with cationic liposome/micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem., 10(14):1195-1211. [doi:10.2174/092 9867033457485]
11. Mo, Z., Liu, Y., Chen, H., Li, H., Sun, Y., 2007. Preparation and molecular dynamics simulation of Sm/PAMAM nano-composite. Rare Metal. Mat. Eng., 36(1):32-36 (in Chinese).
12. Schiavone, N., Donnini, M., Nicolin, A., Capaccioli, S., 2004. Antisense oligonucleotide drug design. Curr. Pharm. Design, 10(7):769-784. [doi:10.2174/1381612043452956]
13. Vattemi, E., Claudio, P.P., 2007. Advances and perspectives in gene-based therapy for breast cancer. Drug Future, 32(6):507-516. [doi:10.1358/dof.2007.032.06.1096368]
14. Wang, Y., Boros, P., Liu, J., Qin, L., Bai, Y., Bielinska, A.U., Kukowska-Latallo, J.F., Baker, J.R., Bromberg, J.S., 2000. DNA/dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo. Mol. Ther., 2(6): 602-608. [doi:10.1006/mthe.2000.0201]
15. Yoo, H., Juliano, R.L., 2000. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res., 28(21):4225-4231. [doi:10.1093/nar/28.21.4225]
16. Zelnak, A.B., O'Regan, R.M., 2007. Targeting angiogenesis in advanced breast cancer. BioDrugs, 21(4):209-214. [doi:10.2165/ 00063030-200721040-00001]